Delivra Health Brands (FRA:3F0) Beta: 5.0211 (As of Jul. 05, 2026)


FRA:3F0 Delivra Health Brands Inc FRA:3F0
28 GF Score
Price €0.04
GF Value €0.09
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Delivra Health Brands Beta?

Delivra Health Brands FRA:3F0 -1.19% 28 Beta is 5.0211 as of Jul. 05, 2026. GuruFocus rates FRA:3F0 with a GF Score™ of 28/100 and a GF Value™ of €0.09 (Possible Value Trap). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-05), Delivra Health Brands's Beta is 5.0211.


Delivra Health Brands  (FRA:3F0) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Delivra Health Brands Beta Related Terms


Delivra Health Brands Beta Historical Data

* Premium members only.

The historical data trend for Delivra Health Brands's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delivra Health Brands Beta Chart

Delivra Health Brands Annual Data
Trend Dec16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.15 3.83 6.37 3.46 4.19

Delivra Health Brands Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.60 4.19 4.64 -7.54 5.21

FRA:3F0 vs ZTS, UTHR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delivra Health Brands Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Beta distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's Beta falls into.


FRA:3F0
28GF Score
Delivra Health Brands Inc FRA:3F0
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delivra Health Brands Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 5.0211 mean?
Delivra Health Brands (FRA:3F0) has a Beta of 5.0211 as of Jul. 05, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Delivra Health Brands and its competitors.
Is Delivra Health Brands' Beta too high?
Delivra Health Brands' current Beta is 5.0211. Overall, Delivra Health Brands has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Delivra Health Brands' Beta compare to ZTS and UTHR?
Delivra Health Brands' Beta of 5.0211 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Delivra Health Brands and its competitors. Delivra Health Brands's current Beta is 5.0211. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (FRA:3F0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.09, compared to a current price of €0.04 — trading 53.9% below its estimated fair value. The current Beta is 5.0211. Delivra Health Brands' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Delivra Health Brands (FRA:3F0), the current Beta is 5.0211 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Delivra Health Brands (FRA:3F0) Overvalued in 2026?

Based on GuruFocus' analysis, Delivra Health Brands stock appears to be undervalued. The current stock price of €0.04 is trading 53.9% below its estimated GF Value™ of €0.09. GuruFocus considers Delivra Health Brands to be Possible Value Trap.

Key valuation signals for FRA:3F0:

  • Beta: 5.0211
  • GF Value™: €0.09 vs. price of €0.04 (53.9% below fair value)
  • GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the FRA:3F0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Delivra Health Brands Business Description

Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
28GF Score

Get the complete analysis for FRA:3F0

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.04
Price
€0.09
GF Value